Cibus Welcomes Landmark EU Decision on Non-Transgenic Crop Breeding

Corteva and Inari announced they have reached a confidential settlement agreement to resolve the lawsuit Corteva filed in September 2023 in the United States District Court for the District of Delaware. Under the settlement, Inari has agreed to destroy Corteva material it accessed from seed depositories, along with material developed from those deposits, and to assign to Corteva the intellectual property related to its edited versions of Corteva events. The two companies also agreed to negotiate certain licensing arrangements, while the remaining terms of the settlement stay confidential. The case is Corteva Agriscience LLC, Pioneer Hi-Bred International, Inc., and Agrigenetics, Inc. v. Inari Agriculture, Inc. and Inari Agriculture NV, C.A. No. 23-1059 (JFM). Corteva and Inari said the rulings reinforce applicable rights over seed deposits and that it is important to abide by applicable patent and other laws and contracts relating to deposited materials.

Vylor, the advanced seed and genetics company spinning off from Corteva on October 1, 2026, and Belgium-based Rainbow Crops, a spin-off from VIB, announced a collaboration to develop new corn traits using artificial intelligence and multiplex gene editing. Under the partnership, both companies will use Rainbow Crops' AI-supported Trait Foundry technology to accelerate development of corn hybrids more resilient to extreme weather such as heat, drought and floods, combining the platform with Vylor's gene editing expertise. Mat Muller, who will lead Vylor Edge, Vylor's investment platform, said the AI-enabled multiplex gene editing capabilities will allow hundreds of gene edits simultaneously, with performance validated in phenotyping facilities and field trials. Giacomo Bastianelli, CEO and co-founder of Rainbow Crops, said early corn work has been an important proof point for the Trait Foundry platform. The collaboration follows the European Parliament's passage on 17 June 2026 of legislation allowing gene-edited plants to be imported and cultivated across the European Union, and comes after Corteva, through its Corteva Catalyst investment platform, participated in Rainbow Crops' recently closed €9.7 million seed financing round, an investment that will become part of the Vylor Edge portfolio upon the separation.

Mosaic Biosciences, a unit of The Mosaic Company, launched Renuvis Enzara, an enzyme-based treatment designed to speed up crop residue breakdown, on August 17, less than two weeks after Mosaic reported a second-quarter net loss of $273 million, a sharp reversal from the $411 million profit it posted in the same quarter of 2025. The product uses endoglucanase enzyme technology that works in soil as cold as 32 degrees Fahrenheit. Mosaic also trimmed its 2026 capital expenditure outlook to $1.2 billion from an earlier $1.25 billion, sold its Carlsbad, New Mexico, potash mine during the quarter, and lined up a $1 billion term loan to refinance and extend its short-term commercial paper, while keeping its regular dividend at $0.22 per share. Second-quarter revenue came in at $2.8 billion, but the company posted an operating loss of $36 million and adjusted EBITDA fell to $407 million from $566 million a year earlier, with Phosphate swinging to an operating loss of $104 million from a loss of $8 million and Mosaic Fertilizantes moving from operating earnings of $109 million to an operating loss of $41 million. Potash was the one stable segment, generating $278 million in adjusted EBITDA, essentially matching the $278 million it produced a year earlier.